Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Apr;48(1):37-42.

Complement-mediated solubilization of immune complexes in systemic lupus erythematosus

Complement-mediated solubilization of immune complexes in systemic lupus erythematosus

T Sakurai et al. Clin Exp Immunol. 1982 Apr.

Abstract

The capacity of complement-mediated solubilization of immune complexes (complex releasing activity: CRA) was studied in 63 sera from eight systemic lupus erythematosus (SLE) patients. CRA in sera of active SLE (35 +/- 17.%) was significantly lower than that of inactive SLE (64.1 +/- 24.1%, P less than 0.001). In addition, 20 of 23 sera collected during active diseases demonstrated CRA values less than 50% of the control pooled serum. On the other hand, CRA of 29 of 40 sera from inactive disease exceeded the 50% level. CRA in SLE sera correlated with complement component levels and in particular with the CH50. Serial determination of CRA and of levels of circulating immune complexes (CIC), C4 and C3 in two active patients indicated that the correlation between CRA and the complement components was positive, while that between CRA and CIC was negative. These studies provide evidence that CRA may be useful for following the activity of SLE and that CRA reflects the levels of the complement components of both classical and alternative pathways. The possibility that CIC may be solubilized and opsonized by complement and cleared by the reticuloendothelial system was discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int Arch Allergy Appl Immunol. 1966;29(2):185-9 - PubMed
    1. N Engl J Med. 1968 Mar 7;278(10):533-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22 - PubMed
    1. J Exp Med. 1975 Jul 1;142(1):139-50 - PubMed
    1. Transplant Rev. 1976;32:121-39 - PubMed

MeSH terms

LinkOut - more resources